Shulamitte Faith Faburada, MLS(ASCP) Janine Anne Juyo, MLS(ASCP) Margarette Denila, MLS(ASCP) Reymond Lim, MLS(ASCP) Johanna Maree Crave, MLS(ASCP) Eanne Jairah Reyes, MLS(ASCP) Stella Ramirez, MLS(ASCP) Lee Marco Mutia, MLS(ASCP) Mary Clare Cesar, MLS(ASCP) Mariam Louise Nisal, MLS(ASCP)
104 Jaltan Bldg. CM Recto cor Bonifacio Street, Davao City 8000, PHL
DTI Cert. No. 00147471
Share MetPath to a friend
Recent Diagnostic Posts
Safety Tests Of Ebola Vaccines To Start This Fall.
The AP (Perrone, Neergaard) reports that safety trials are to begin for two experimental Ebola vaccines. Safety tests “typically are performed on a few dozen to 100 people.” The first, “developed by researchers at the National Institutes of Health” and GlaxoSmithKline should be tested in the next few months and is “based on a chimpanzee adenovirus.” Dr. Anthony Fauci has explained that it is “purely preventive, more aimed at giving it to the health care workers who put themselves at considerable danger.” The second, developed by researchers at the Canadian national laboratory and NewLink Genetics of Ames, Iowa, is expected to be tested “in up to 100 health volunteers with the FDA” though the timetable has not been set. The NIH is also supporting development of “at least two other candidate Ebola vaccines,” the first from Crucell, which “could begin human testing by late 2015,” and the second from Profectus Biosciences.